Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Sutro Biopharma (STRO) Other Operating Expenses (2025)

Sutro Biopharma's Other Operating Expenses history spans 1 years, with the latest figure at $2.8 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses changed N/A to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.3 million, a N/A change, with the full-year FY2025 number at -$9.8 million, changed N/A from a year prior.
  • Other Operating Expenses hit $2.8 million in Q4 2025 for Sutro Biopharma, up from $2.2 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for STRO hit a ceiling of $16.8 million in Q1 2025 and a floor of $2.2 million in Q3 2025.